NasdaqCM - Nasdaq Real Time Price USD

AdaptHealth Corp. (AHCO)

Compare
10.63 +0.07 (+0.66%)
As of 3:18 PM EDT. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
3,249,902.00
3,200,177.00
2,970,595.00
2,454,535.00
1,056,389.00
--
Cost of Revenue
2,746,486.00
2,720,613.00
2,553,169.00
2,008,925.00
898,601.00
--
Gross Profit
503,416.00
479,564.00
417,426.00
445,610.00
157,788.00
--
Operating Expense
235,813.00
247,178.00
227,015.00
220,005.00
86,442.00
--
Operating Income
267,603.00
232,386.00
190,411.00
225,605.00
71,346.00
--
Net Non Operating Interest Income Expense
-131,302.00
-130,299.00
-109,414.00
-95,195.00
-41,430.00
--
Other Income Expense
-862,206.00
-825,871.00
16,905.00
60,549.00
-235,957.00
--
Pretax Income
-725,905.00
-723,784.00
97,902.00
190,959.00
-206,041.00
--
Tax Provision
-38,831.00
-49,004.00
24,769.00
32,806.00
-11,955.00
--
Net Income Common Stockholders
-690,245.00
-678,895.00
63,449.00
141,796.00
-161,632.00
--
Average Dilution Earnings
-11,756.00
-34,482.00
-17,158.00
-53,181.00
--
--
Diluted NI Available to Com Stockholders
-702,001.00
-713,377.00
46,291.00
88,615.00
-161,632.00
--
Basic EPS
-5.14
-5.06
0.47
1.12
-1.23
--
Diluted EPS
-5.22
-5.31
0.33
0.67
-1.23
--
Basic Average Shares
133,484.50
134,156.00
134,175.00
126,306.00
52,488.00
--
Diluted Average Shares
133,484.50
134,418.00
138,988.00
133,034.00
52,488.00
--
Total Operating Income as Reported
-576,262.00
-598,401.00
190,411.00
225,605.00
71,346.00
--
Rent Expense Supplemental
70,268.00
67,783.00
64,375.00
48,586.00
22,344.00
--
Total Expenses
2,982,299.00
2,967,791.00
2,780,184.00
2,228,930.00
985,043.00
--
Net Income from Continuing & Discontinued Operation
-691,278.00
-678,895.00
69,316.00
156,175.00
-161,632.00
--
Normalized Income
96,738.11
63,261.26
56,498.97
104,523.53
63,883.74
--
Interest Expense
131,302.00
130,299.00
109,414.00
95,195.00
41,430.00
--
Net Interest Income
-131,302.00
-130,299.00
-109,414.00
-95,195.00
-41,430.00
--
EBIT
-594,603.00
-593,485.00
207,316.00
286,154.00
-164,611.00
--
EBITDA
-220,891.00
-210,702.00
558,494.00
544,207.00
-82,166.00
--
Reconciled Cost of Revenue
2,421,540.00
2,394,917.00
2,266,881.00
1,813,967.00
827,529.00
--
Reconciled Depreciation
373,712.00
382,783.00
351,178.00
258,053.00
82,445.00
--
Net Income from Continuing Operation Net Minority Interest
-691,278.00
-678,895.00
69,316.00
156,175.00
-161,632.00
--
Total Unusual Items Excluding Goodwill
-832,552.00
-796,305.00
17,158.00
62,381.00
-239,401.00
--
Total Unusual Items
-832,552.00
-796,305.00
17,158.00
62,381.00
-239,401.00
--
Normalized EBITDA
611,661.00
585,603.00
541,336.00
481,826.00
157,235.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
-44,535.89
-54,148.74
4,340.97
10,729.53
-13,885.26
--
12/31/2019 - 5/31/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers